期刊文献+

甲氨蝶呤预防腹腔镜手术后持续性异位妊娠的研究 被引量:41

Methotrexate Prophylaxis for Persistent Ectopic Pregnancy after Laparoscopic Conservative Surgery
暂未订购
导出
摘要 目的:探讨异位妊娠腹腔镜保守性手术后预防持续性异位妊娠(PEP)的方法。方法:对86例输卵管妊娠患者行腹腔镜保守性手术后随机分成两组:A组采用甲氨蝶呤(MTX)注入患侧输卵管近端残腔;B组除用MTX外,并于术后口服米非司酮。所有患者均于术前及术后24小时、72小时、7天、12天检测血-βHCG值并观察其毒副反应的发生。结果:A组PEP发生1例(2.27%),B组2例(4.76%),差异无显著性(P>0.05);术后24小时血-βHCG值较术前明显下降(P<0.01),但两组间差异无显著性(P>0.05);术后72小时、7天血-βHCG值两组间差异无显著性(P>0.05),但12天两组间差异有非常显著性,B组明显高于A组(P<0.01);且B组出现的毒副反应明显多于A组。结论:单用MTX对异位妊娠腹腔镜保守性手术后预防PEP发生,可能要优于MTX加米非司酮。 Objective: To evaluate the efficacy of Methotrexate (MTX) prophylaxis for persistent ectopic pregnancy (PEP) after laparoscopic conservative surgery for tubal pregnancy. Methods:86 patients with tubal pregnancy who underwent laparoscopic conservative surgery were randomly divided into two groups:A group (44 patients) with local injection of MTX alone, B group (42 patients) with MTX local injection and consequently oral Mifepristore. Serum β- HCG values were examined before- and after-treatment, and the occurrence of PEP or side reactions were obsewed in all of patients. Results:The occurrence rate of PEP in group A and B group was 2.27% and 4.76%, separately,no significant difference ( P〉 0.05).Serum β-HCG values dropped quickly postoperatively in all patients,the differences of serum β-HCG values in 24 hours,72 hours,and 7 days of post-operation were not significant between two groups (P〉0.05) .However, on the 12 day of post-operation, serum β-HCG in A group was signifk:ant lower than B group ( P 〈 0.01 ). And the side reactions in group B were greater than that in group A. Conclusions: Patients who were treated with MTX alone after laparoscopic conservative surgery may present fewer side reactions and rapidly serum β-hCG value reduction.
作者 龙滨 徐高生
出处 《实用妇产科杂志》 CAS CSCD 北大核心 2006年第6期351-353,共3页 Journal of Practical Obstetrics and Gynecology
关键词 甲氨堞呤 腹腔镜 持续性异位妊娠 保守性手术 Methotrexate (MTX) Laparoscopy Persistent ectopic pregnancy (PEP) Conservative surgery
  • 相关文献

参考文献5

二级参考文献23

  • 1[1]Clarisa R. Gracia MD, Hillary A, et al. Prophylactic methotrexate after linear salpingostomy: a decision analysis. Fertil Steril, 2001, 76:1191-1195.
  • 2[2]Jacek W, Graczykowski MD, Daniel R, et al. Methotrexate Prophylaxis for Persistent Ectopic Pregnancy After Conservative Treatment by Salpingostomy. Obstet Gynecol, 1997, 89:118-122.
  • 3[3]Vermesh M, Silva PD, Sauer MV, et al. Persistent tube ectopic gastation; pattern of circulating beta-human chorionic gonadotropin and progesterone, and management options. Fertility Sterility, 1988, 50:584-588.
  • 4[4]Seifer DB, Diamond MP, DeCherney AH. Persistent ectopic pregnancy. Obstet Gynecol Clin North Am, 1991, 18:153-159.
  • 5[5]Seifer DB, Gutmann JN, Grant WD, et al. Comparison of persistent ectopic pregnancy after laparoscopic salpingostomy versus salingostomy at laparotomy for ectopic pregnancy. Obstet Gynecol, 1993, 81:378-382.
  • 6[6]Seifer DB, Gutmann JN, Doyle MB, et al. Persistent ectopic pregnancy following laparoscopic linear salpingostomy. Am J Obstet Gynecol, 1990, 76:1121-1125.
  • 7[7]Kemmann E, Trout S, Garcia A. Can we predict patients at risk for persistent ectopic pregnancy after laparoscopic salpingostomy? J Am Assoc Gynecol Laparosc, 1994, 1:122-126.
  • 8[8]Parmley TH. The histopathology of tubal pregnancy. Clini Obstet Gynecol, 1987, 30:119-128.
  • 9[10]Decherney, Romero, Naftolin. Surgical management of unruptured ectopic pregnancy. Fertil Steril, 1981, 35:21-24.
  • 10[11]Poppe WA,Vandenbussche N. Postoperative day 3 serum human chorionic gonadotropin decline as a predictor of persistent ectopic pregnancy after linear salpingotomy. European Journal of Obstetrics Gynecology and Reproductive Biology, 2001, 99:249-252.

共引文献86

同被引文献174

引证文献41

二级引证文献179

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部